← Open Payments lookup

TAI UGBE: Open Payments

NPI 1750967261 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$513 in 28 payments from 9 companies in 2025. Trend: 2023 $366 · 2024 $750 · 2025 $513

Food & beverage: $503Education: $10
CompanyPaymentsAmount
ABBVIE INC.14$207
Neurocrine BioSciences, Inc.4$103
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$56
Janssen Pharmaceuticals, Inc2$41
Lundbeck LLC1$28
Alkermes, Inc.1$22
Takeda Pharmaceuticals U.S.A., Inc.1$21
Otsuka America Pharmaceutical, Inc.1$19
Teva Pharmaceuticals USA, Inc.1$16

Products named: VRAYLAR, INGREZZA, CAPLYTA, REXULTI, INVEGA SUSTENNA, ARISTADA, TRINTELLIX, INVEGA.

Industry payments across TX — which companies pay providers there.